APO Research
Talk to an analyst

APO RESEARCH · REPORT

Passive Temperature Controlled Packaging in Pharma

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Passive Temperature Controlled Packaging in Pharma Market Outlook and Growth Opportunities 2026

30 December 2025194 pages

Choose your research edition.

Industry ResearchPassive Temperature Controlled Packaging in Pharma Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Passive Temperature Controlled Packaging in Pharma Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Passive Temperature Controlled Packaging in Pharma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Passive Temperature Controlled Packaging in Pharma Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Passive Temperature Controlled Packaging in Pharma Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Passive Temperature Controlled Packaging in Pharma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Passive Temperature Controlled Packaging in Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Passive Temperature Controlled Packaging in Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Passive Temperature Controlled Packaging in Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Passive Temperature Controlled Packaging in Pharma market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Passive Temperature Controlled Packaging in Pharma market include Sonoco ThermoSafe, Hazgo, Cold Chain Technologies, Marken and Jarden Life Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Passive Temperature Controlled Packaging in Pharma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Passive Temperature Controlled Packaging in Pharma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Passive Temperature Controlled Packaging in Pharma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Passive Temperature Controlled Packaging in Pharma market size, projected growth trends, production technologies, key applications, and end-use industries.

Passive Temperature Controlled Packaging in Pharma Segment by Company

Sonoco ThermoSafe

Hazgo

Cold Chain Technologies

Marken

Jarden Life Sciences

Passive Temperature Controlled Packaging in Pharma Segment by Type

Insulated Boxes

Insulated Containers

Other

Passive Temperature Controlled Packaging in Pharma Segment by Application

Pharma Industry

Others

Passive Temperature Controlled Packaging in Pharma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Passive Temperature Controlled Packaging in Pharma status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Passive Temperature Controlled Packaging in Pharma market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Passive Temperature Controlled Packaging in Pharma significant trends, drivers, influence factors in global and regions.

6. To analyze Passive Temperature Controlled Packaging in Pharma competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Passive Temperature Controlled Packaging in Pharma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Passive Temperature Controlled Packaging in Pharma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Passive Temperature Controlled Packaging in Pharma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Passive Temperature Controlled Packaging in Pharma market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Passive Temperature Controlled Packaging in Pharma industry.

Chapter 3: Detailed analysis of Passive Temperature Controlled Packaging in Pharma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Passive Temperature Controlled Packaging in Pharma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Passive Temperature Controlled Packaging in Pharma in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Passive Temperature Controlled Packaging in Pharma Industry Trends Table 2. Passive Temperature Controlled Packaging in Pharma Industry Drivers Table 3. Passive Temperature Controlled Packaging in Pharma Industry Opportunities and Challenges Table 4. Passive Temperature Controlled Packaging in Pharma Industry Restraints Table 5. Global Passive Temperature Controlled Packaging in Pharma Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Passive Temperature Controlled Packaging in Pharma Revenue Share by Company (2021-2026) Table 7. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Company (k units) & (2021-2026) Table 8. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Company (2021-2026) Table 9. Global Passive Temperature Controlled Packaging in Pharma Average Price (USD/unit) of Company (2021-2026) Table 10. Global Passive Temperature Controlled Packaging in Pharma Company Ranking, (2024-2026) & (USD Million) Table 11. Global Passive Temperature Controlled Packaging in Pharma Key Company Manufacturing Base & Headquarters Table 12. Global Passive Temperature Controlled Packaging in Pharma Company, Product Type & Application Table 13. Global Passive Temperature Controlled Packaging in Pharma Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Passive Temperature Controlled Packaging in Pharma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Insulated Boxes Table 18. Significant Companies of Insulated Containers Table 19. Significant Companies of Other Table 20. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Type (2021-2026) & (k units) Table 22. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Type (2027-2032) & (k units) Table 23. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Type (2021-2026) Table 24. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Type (2027-2032) Table 25. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type (2021-2026) Table 29. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharma Industry Table 31. Significant Companies of Others Table 32. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Application (2021-2026) & (k units) Table 34. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Application (2027-2032) & (k units) Table 35. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Application (2021-2026) Table 36. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Application (2027-2032) Table 37. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application (2021-2026) Table 41. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application (2027-2032) Table 42. Global Passive Temperature Controlled Packaging in Pharma Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Passive Temperature Controlled Packaging in Pharma Sales by Region (2021-2026) & (k units) Table 44. Global Passive Temperature Controlled Packaging in Pharma Sales Market Share by Region (2021-2026) Table 45. Global Passive Temperature Controlled Packaging in Pharma Sales by Region (2027-2032) & (k units) Table 46. Global Passive Temperature Controlled Packaging in Pharma Sales Market Share by Region (2027-2032) Table 47. Global Passive Temperature Controlled Packaging in Pharma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Region (2021-2026) Table 50. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Region (2027-2032) Table 52. Global Passive Temperature Controlled Packaging in Pharma Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Passive Temperature Controlled Packaging in Pharma Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Passive Temperature Controlled Packaging in Pharma Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Passive Temperature Controlled Packaging in Pharma Sales by Country (2021-2026) & (k units) Table 57. Global Passive Temperature Controlled Packaging in Pharma Sales Market Share by Country (2021-2026) Table 58. Global Passive Temperature Controlled Packaging in Pharma Sales by Country (2027-2032) & (k units) Table 59. Global Passive Temperature Controlled Packaging in Pharma Sales Market Share by Country (2027-2032) Table 60. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Passive Temperature Controlled Packaging in Pharma Sales Value Market Share by Country (2021-2026) Table 62. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Passive Temperature Controlled Packaging in Pharma Sales Value Market Share by Country (2027-2032) Table 64. Sonoco ThermoSafe Company Information Table 65. Sonoco ThermoSafe Business Overview Table 66. Sonoco ThermoSafe Passive Temperature Controlled Packaging in Pharma Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Sonoco ThermoSafe Passive Temperature Controlled Packaging in Pharma Product Portfolio Table 68. Sonoco ThermoSafe Recent Development Table 69. Hazgo Company Information Table 70. Hazgo Business Overview Table 71. Hazgo Passive Temperature Controlled Packaging in Pharma Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Hazgo Passive Temperature Controlled Packaging in Pharma Product Portfolio Table 73. Hazgo Recent Development Table 74. Cold Chain Technologies Company Information Table 75. Cold Chain Technologies Business Overview Table 76. Cold Chain Technologies Passive Temperature Controlled Packaging in Pharma Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Cold Chain Technologies Passive Temperature Controlled Packaging in Pharma Product Portfolio Table 78. Cold Chain Technologies Recent Development Table 79. Marken Company Information Table 80. Marken Business Overview Table 81. Marken Passive Temperature Controlled Packaging in Pharma Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Marken Passive Temperature Controlled Packaging in Pharma Product Portfolio Table 83. Marken Recent Development Table 84. Jarden Life Sciences Company Information Table 85. Jarden Life Sciences Business Overview Table 86. Jarden Life Sciences Passive Temperature Controlled Packaging in Pharma Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Jarden Life Sciences Passive Temperature Controlled Packaging in Pharma Product Portfolio Table 88. Jarden Life Sciences Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Passive Temperature Controlled Packaging in Pharma Distributors List Table 92. Passive Temperature Controlled Packaging in Pharma Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Passive Temperature Controlled Packaging in Pharma Product Image Figure 2. Global Passive Temperature Controlled Packaging in Pharma Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032) & (US$ Million) Figure 4. Global Passive Temperature Controlled Packaging in Pharma Sales (2021-2032) & (k units) Figure 5. Global Passive Temperature Controlled Packaging in Pharma Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Passive Temperature Controlled Packaging in Pharma Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Insulated Boxes Image Figure 10. Insulated Containers Image Figure 11. Other Image Figure 12. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Type (2021-2032) Figure 15. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type (2021-2032) Figure 18. Pharma Industry Image Figure 19. Others Image Figure 20. Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Application (2021-2032) Figure 23. Global Passive Temperature Controlled Packaging in Pharma Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application (2021-2032) Figure 26. Global Passive Temperature Controlled Packaging in Pharma Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Passive Temperature Controlled Packaging in Pharma Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Passive Temperature Controlled Packaging in Pharma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032) & (US$ Million) Figure 31. North America Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032) & (US$ Million) Figure 37. South America Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Passive Temperature Controlled Packaging in Pharma Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Passive Temperature Controlled Packaging in Pharma Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Insulated Boxes
  • Insulated Containers
  • Other
Applications
  • Pharma Industry
  • Others
Companies covered
  • Sonoco ThermoSafe
  • Hazgo
  • Cold Chain Technologies
  • Marken
  • Jarden Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032)
  4. 1.2.2 Global Passive Temperature Controlled Packaging in Pharma Sales Volume (2021-2032)
  5. 1.2.3 Global Passive Temperature Controlled Packaging in Pharma Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Passive Temperature Controlled Packaging in Pharma Market Dynamics
  1. 2.1 Passive Temperature Controlled Packaging in Pharma Industry Trends
  2. 2.2 Passive Temperature Controlled Packaging in Pharma Industry Drivers
  3. 2.3 Passive Temperature Controlled Packaging in Pharma Industry Opportunities and Challenges
  4. 2.4 Passive Temperature Controlled Packaging in Pharma Industry Restraints
3 Passive Temperature Controlled Packaging in Pharma Market by Company
  1. 3.1 Global Passive Temperature Controlled Packaging in Pharma Company Revenue Ranking in 2025
  2. 3.2 Global Passive Temperature Controlled Packaging in Pharma Revenue by Company (2021-2026)
  3. 3.3 Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Company (2021-2026)
  4. 3.4 Global Passive Temperature Controlled Packaging in Pharma Average Price by Company (2021-2026)
  5. 3.5 Global Passive Temperature Controlled Packaging in Pharma Company Ranking (2024-2026)
  6. 3.6 Global Passive Temperature Controlled Packaging in Pharma Company Manufacturing Base and Headquarters
  7. 3.7 Global Passive Temperature Controlled Packaging in Pharma Company Product Type and Application
  8. 3.8 Global Passive Temperature Controlled Packaging in Pharma Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Passive Temperature Controlled Packaging in Pharma Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Passive Temperature Controlled Packaging in Pharma Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Passive Temperature Controlled Packaging in Pharma Market by Type
  1. 4.1 Passive Temperature Controlled Packaging in Pharma Type Introduction
  2. 4.1.1 Insulated Boxes
  3. 4.1.2 Insulated Containers
  4. 4.1.3 Other
  5. 4.2 Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Type
  6. 4.2.1 Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Type
  10. 4.3.1 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Type (2021-2032)
  12. 4.3.3 Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type (2021-2032)
5 Passive Temperature Controlled Packaging in Pharma Market by Application
  1. 5.1 Passive Temperature Controlled Packaging in Pharma Application Introduction
  2. 5.1.1 Pharma Industry
  3. 5.1.2 Others
  4. 5.2 Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Application
  5. 5.2.1 Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Passive Temperature Controlled Packaging in Pharma Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Passive Temperature Controlled Packaging in Pharma Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Application
  9. 5.3.1 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Application (2021-2032)
  11. 5.3.3 Global Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application (2021-2032)
6 Passive Temperature Controlled Packaging in Pharma Regional Sales and Value Analysis
  1. 6.1 Global Passive Temperature Controlled Packaging in Pharma Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Region (2021-2032)
  3. 6.2.1 Global Passive Temperature Controlled Packaging in Pharma Sales by Region: 2021-2026
  4. 6.2.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Region (2027-2032)
  5. 6.3 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Region (2021-2032)
  7. 6.4.1 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Region: 2021-2026
  8. 6.4.2 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Region (2027-2032)
  9. 6.5 Global Passive Temperature Controlled Packaging in Pharma Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032)
  12. 6.6.2 North America Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032)
  15. 6.7.2 Europe Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032)
  21. 6.9.2 South America Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Passive Temperature Controlled Packaging in Pharma Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Passive Temperature Controlled Packaging in Pharma Sales Value Share by Country, 2025 VS 2032
7 Passive Temperature Controlled Packaging in Pharma Country-level Sales and Value Analysis
  1. 7.1 Global Passive Temperature Controlled Packaging in Pharma Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Passive Temperature Controlled Packaging in Pharma Sales by Country (2021-2032)
  4. 7.3.1 Global Passive Temperature Controlled Packaging in Pharma Sales by Country (2021-2026)
  5. 7.3.2 Global Passive Temperature Controlled Packaging in Pharma Sales by Country (2027-2032)
  6. 7.4 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Country (2021-2032)
  7. 7.4.1 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Country (2021-2026)
  8. 7.4.2 Global Passive Temperature Controlled Packaging in Pharma Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Passive Temperature Controlled Packaging in Pharma Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Passive Temperature Controlled Packaging in Pharma Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Passive Temperature Controlled Packaging in Pharma Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sonoco ThermoSafe
  2. 8.1.1 Sonoco ThermoSafe Company Information
  3. 8.1.2 Sonoco ThermoSafe Business Overview
  4. 8.1.3 Sonoco ThermoSafe Passive Temperature Controlled Packaging in Pharma Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sonoco ThermoSafe Passive Temperature Controlled Packaging in Pharma Product Portfolio
  6. 8.1.5 Sonoco ThermoSafe Recent Developments
  7. 8.2 Hazgo
  8. 8.2.1 Hazgo Company Information
  9. 8.2.2 Hazgo Business Overview
  10. 8.2.3 Hazgo Passive Temperature Controlled Packaging in Pharma Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hazgo Passive Temperature Controlled Packaging in Pharma Product Portfolio
  12. 8.2.5 Hazgo Recent Developments
  13. 8.3 Cold Chain Technologies
  14. 8.3.1 Cold Chain Technologies Company Information
  15. 8.3.2 Cold Chain Technologies Business Overview
  16. 8.3.3 Cold Chain Technologies Passive Temperature Controlled Packaging in Pharma Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cold Chain Technologies Passive Temperature Controlled Packaging in Pharma Product Portfolio
  18. 8.3.5 Cold Chain Technologies Recent Developments
  19. 8.4 Marken
  20. 8.4.1 Marken Company Information
  21. 8.4.2 Marken Business Overview
  22. 8.4.3 Marken Passive Temperature Controlled Packaging in Pharma Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Marken Passive Temperature Controlled Packaging in Pharma Product Portfolio
  24. 8.4.5 Marken Recent Developments
  25. 8.5 Jarden Life Sciences
  26. 8.5.1 Jarden Life Sciences Company Information
  27. 8.5.2 Jarden Life Sciences Business Overview
  28. 8.5.3 Jarden Life Sciences Passive Temperature Controlled Packaging in Pharma Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jarden Life Sciences Passive Temperature Controlled Packaging in Pharma Product Portfolio
  30. 8.5.5 Jarden Life Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Passive Temperature Controlled Packaging in Pharma Value Chain Analysis
  2. 9.1.1 Passive Temperature Controlled Packaging in Pharma Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Passive Temperature Controlled Packaging in Pharma Sales Mode & Process
  6. 9.2 Passive Temperature Controlled Packaging in Pharma Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Passive Temperature Controlled Packaging in Pharma Distributors
  9. 9.2.3 Passive Temperature Controlled Packaging in Pharma Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst